SARS-CoV-2 versus Influenza A Virus: Characteristics and Co-Treatments

被引:3
作者
Wang, Xinyi [1 ]
Li, Jingwen [1 ]
Liu, Hanshu [1 ]
Hu, Xinyu [1 ]
Lin, Zhicheng [2 ]
Xiong, Nian [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430000, Peoples R China
[2] Harvard Med Sch, Mclean Hosp, Belmont, MA 02478 USA
基金
英国科研创新办公室; 中国国家自然科学基金;
关键词
SARS-CoV-2; influenza A; co-treatments; variants; smoking and alcohol use; ALCOHOL-USE; COVID-19; LOCKDOWN; T-CELLS; INNATE; RESPONSES; SMOKING; CONSUMPTION; VACCINATION; MECHANISMS; DIAGNOSIS;
D O I
10.3390/microorganisms11030580
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
For three years, the novel coronavirus disease 2019 (COVID-19) pandemic, caused by infection of the SARS-CoV-2 virus, has completely changed our lifestyles and prepared us to live with this novel pneumonia for years to come. Given that pre-existing flu is caused by the influenza A virus, we have begun unprecedently co-coping with two different respiratory diseases at the same time. Hence, we draw a comparison between SARS-CoV-2 and influenza A virus based on the general characteristics, especially the main variants' history and the distribution of the two viruses. SARS-CoV-2 appeared to mutate more frequently and independently of locations than the influenza A virus. Furthermore, we reviewed present clinical trials on combined management against COVID-19 and influenza in order to explore better solutions against both at the same time.
引用
收藏
页数:23
相关论文
共 147 条
  • [1] Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
    Abdelrahman, Zeinab
    Li, Mengyuan
    Wang, Xiaosheng
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [2] Abdullahi Idris Nasir, 2020, Infez Med, V28, P166
  • [3] Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
    Accorsi, Emma K.
    Britton, Amadea
    Fleming-Dutra, Katherine E.
    Smith, Zachary R.
    Shang, Nong
    Derado, Gordana
    Miller, Joseph
    Schrag, Stephanie J.
    Verani, Jennifer R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (07): : 639 - 651
  • [4] Clinical Characteristics and Predictors of 28-Day Mortality in 352 Critically Ill Patients with COVID-19: A Retrospective Study
    Alharthy, Abdulrahman
    Aletreby, Waleed
    Faqihi, Fahad
    Balhamar, Abdullah
    Alaklobi, Feisal
    Alanezi, Khaled
    Jaganathan, Parameaswari
    Tamim, Hani
    Alqahtani, Saleh A.
    Karakitsos, Dimitrios
    Memish, Ziad A.
    [J]. JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH, 2021, 11 (01) : 98 - 104
  • [5] Proportion of community-acquired pneumonia cases attributable to tobacco smoking
    Almirall, J
    González, CA
    Balanzó, X
    Bolíbar, I
    [J]. CHEST, 1999, 116 (02) : 375 - 379
  • [6] Andrews N, 2022, NEW ENGL J MED, V386, P1532, DOI [10.1016/S1473-3099(22)00309-7, 10.1056/NEJMoa2119451]
  • [7] Alcohol-related harm during the COVID-19 pandemic
    不详
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (07): : 511 - 511
  • [8] [Anonymous], TRACK SARS COV 2 VAR
  • [9] [Anonymous], WHO Coronavirus (COVID-19) Dashboard
  • [10] Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines
    Araf, Yusha
    Akter, Fariya
    Tang, Yan-dong
    Fatemi, Rabeya
    Parvez, Md Sorwer Alam
    Zheng, Chunfu
    Hossain, Md Golzar
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) : 1825 - 1832